JEOL (6951) investor relations material

Executive summary

• Q3 FY2025 revenue and profit declined year-over-year but remained generally in line with the announced plan.

• Net sales for the nine months ended December 31, 2025, were ¥129.8 billion, down 4.8% year-over-year.

• Operating profit decreased 18.6% to ¥21.4 billion, and net profit fell 12.3% to ¥17.5 billion compared to the same period last year.

• Japan saw robust science and technology investment, while the US and Europe faced uncertainty due to policy shifts and funding cuts.

• Asia, including China, remained relatively stable despite trade friction concerns.

Financial highlights

• Q3 FY2025 consolidated net sales: ¥129.8 billion (-4.8% YoY); operating profit: ¥21.4 billion (-18.6% YoY).

• Net profit for Q3 FY2025: ¥17.5 billion (-12.3% YoY).

• Full-year FY2025 forecast: net sales ¥181 billion (-8.0% YoY), operating profit ¥24 billion (-32.4% YoY), ordinary profit ¥24.5 billion (-28.8% YoY), net profit ¥18 billion (-3.7% YoY), and basic EPS ¥352.09.

• Gross profit for the nine months was ¥62.29 billion, down from ¥67.16 billion year-over-year.

• Declines attributed to lower sales volume, unfavorable product mix, and yen appreciation.

Outlook and guidance

• No change to the FY2025 full-year forecast or dividend forecast.

• Scientific and Metrology Instruments expected to maintain sales despite US tariffs and China export controls.

• Industrial Equipment segment awaits recovery in multi-beam mask writer demand.